Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yang-Xin Fu

Showing results (21-30 of 337) with videos related to

Pageof 34
Sort By:
Gastroenterology|June 24, 2020
The Inhibitory PVRL1/PVR/TIGIT Axis in Immune Therapy for Hepatocellular CarcinomaHua Peng, Yang-Xin Fu
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 1, 2006
Tumor-infiltrating T lymphocytes: friends or foes?Ping Yu, Yang-Xin Fu
Cellular & Molecular Immunology|February 25, 2024
Inactivation of TGF-β signaling in CAR-T cellsZaopeng Yang, Yang-Xin Fu
The Journal of Clinical Investigation|August 25, 2015
The tragic fate of group 3 innate lymphoid cells during HIV-1 infectionXiaohuan Guo, Yang-Xin Fu
Cell Metabolism|April 10, 2018
Immune Evasion in Tumor's Own Sweet WayHaidong Tang, Yang-Xin Fu
Cell Stem Cell|March 8, 2024
Promises and challenges of organoids: From humanized to human derivedWenyan Wang, Yang-Xin Fu
Oncoimmunology|March 8, 2014
Anti-HER2/Neu passive-aggressive immunotherapyEric D Mortenson, Yang-Xin Fu
Current Pathobiology Reports|February 20, 2013
Adaptive Immune Responses and HER2/neu Positive Breast CancerEric D Mortenson, Yang-Xin Fu
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|October 19, 2013
[Design of next generation antibody drug conjugates]Gui-Dong Zhu, Yang-Xin Fu
Transplantation|September 30, 2011
Attenuation by targeting the B- and T-cell attenuatorMaria-Luisa Alegre, Yang-Xin Fu
Pageof 34

Showing results (21-30 of 337) with videos related to

Sort By:
Pageof 34
Gastroenterology|June 24, 2020
The Inhibitory PVRL1/PVR/TIGIT Axis in Immune Therapy for Hepatocellular CarcinomaHua Peng, Yang-Xin Fu
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 1, 2006
Tumor-infiltrating T lymphocytes: friends or foes?Ping Yu, Yang-Xin Fu
Cellular & Molecular Immunology|February 25, 2024
Inactivation of TGF-β signaling in CAR-T cellsZaopeng Yang, Yang-Xin Fu
The Journal of Clinical Investigation|August 25, 2015
The tragic fate of group 3 innate lymphoid cells during HIV-1 infectionXiaohuan Guo, Yang-Xin Fu
Cell Metabolism|April 10, 2018
Immune Evasion in Tumor's Own Sweet WayHaidong Tang, Yang-Xin Fu
Cell Stem Cell|March 8, 2024
Promises and challenges of organoids: From humanized to human derivedWenyan Wang, Yang-Xin Fu
Oncoimmunology|March 8, 2014
Anti-HER2/Neu passive-aggressive immunotherapyEric D Mortenson, Yang-Xin Fu
Current Pathobiology Reports|February 20, 2013
Adaptive Immune Responses and HER2/neu Positive Breast CancerEric D Mortenson, Yang-Xin Fu
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|October 19, 2013
[Design of next generation antibody drug conjugates]Gui-Dong Zhu, Yang-Xin Fu
Transplantation|September 30, 2011
Attenuation by targeting the B- and T-cell attenuatorMaria-Luisa Alegre, Yang-Xin Fu
Pageof 34